Litcius/Paper detail

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

Athanasios Chalkias, Angeliki Mouzarou, Evangelia Samara, Theodoros Xanthos, Eleni Ischaki, Ioannis Pantazopoulos

2020Molecular Diagnosis & Therapy30 citationsDOIOpen Access PDF

Topics & Concepts

SuPARMedicineBiomarkerIntensive care unitPneumoniaIntensive care medicineTriageInternal medicinePlasminogen activatorIntensive careSeverity of illnessPopulationUrokinase receptorEmergency medicineBiologyBiochemistryEnvironmental healthCOVID-19 Clinical Research StudiesPancreatitis Pathology and TreatmentInflammatory Biomarkers in Disease Prognosis
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients | Litcius